Your browser doesn't support javascript.
loading
Efficacy of Plinabulin vs Pegfilgrastim for Prevention of Docetaxel-Induced Neutropenia in Patients With Solid Tumors: A Randomized Clinical Trial.
Blayney, Douglas W; Mohanlal, Ramon; Adamchuk, Hryhoriy; Kirtbaya, Dmitry Valikovich; Chen, Michael; Du, Lihua; Ogenstad, Stephan; Ginn, Greg; Huang, Lan; Zhang, Qingyuan.
Afiliação
  • Blayney DW; Stanford Cancer Institute, Stanford, California.
  • Mohanlal R; BeyondSpring Pharmaceuticals, New York, New York.
  • Adamchuk H; MI Kriviy Rih Oncology Dispensary, Krivoy Rog, Ukraine.
  • Kirtbaya DV; SBI of Healthcare Oncology Dispensary 2, Ministry of Healthcare of Krasnodar Region 38, Sochi, Russia.
  • Chen M; TCM Groups, Inc, Berkeley Heights, New Jersey.
  • Du L; Dalian Wanchun Bulin Pharmaceuticals Limited, Dalian, China.
  • Ogenstad S; Statogen Consulting, LLC, Wake Forest, North Carolina.
  • Ginn G; Statogen Consulting, LLC, Wake Forest, North Carolina.
  • Huang L; BeyondSpring Pharmaceuticals, New York, New York.
  • Zhang Q; The Third of Internal Medicine Department, Harbin Medical University Cancer Hospital, Harbin, China.
JAMA Netw Open ; 5(1): e2145446, 2022 01 04.
Article em En | MEDLINE | ID: mdl-35084480

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Polietilenoglicóis / Dicetopiperazinas / Filgrastim / Docetaxel / Neoplasias / Neutropenia / Antineoplásicos Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Polietilenoglicóis / Dicetopiperazinas / Filgrastim / Docetaxel / Neoplasias / Neutropenia / Antineoplásicos Idioma: En Ano de publicação: 2022 Tipo de documento: Article